Medtronic plc (NYSE:MDT) is included among the 13 Cheapest Dividend Aristocrats to Invest in. On February 9, Needham & ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 results ...

Medtronic plc MDT has shared late-breaking clinical trial results for its PulseSelect Pulsed Field Ablation (“PFA”) system, demonstrating a high rate of durable lesion formation in treating atrial ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) clearance for its new InPen app, which features missed meal dose detection. This latest FDA clearance should pave the way for ...

Medtronic MDT has started the year 2025 on a positive note, with the stock climbing nearly 7% so far in January. This surge in market optimism follows the CMS' recent move to initiate a national ...

Medtronic plc (NYSE:MDT) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 4, UBS raised its ...

Medtronic remains an attractive investment due to its diversified revenue streams, robust product pipeline and improving margins. MDT's growth is driven by strong performance in Neuroscience, ...

We recently compiled a list titled Jim Cramer’s Latest Watchlist: 10 Stock Picks You Need to Know. In this article, we will look at where Medtronic plc (NYSE:MDT) stands among other stock picks in Jim ...